Table 2 Summary of event rates with confidence intervals (CIs) for carbapenem-resistant hvKp strains
WHO region | Carbapenem | Random-effect model | Heterogeneity | Publication bias | ||
|---|---|---|---|---|---|---|
% | 95%CI | I2 | p-value | Egger’s p-value | ||
West pacific region | Carbapenem | 54.7 | 29.5–77.6 | 90.2 | 0.01 | 0.01 |
blaVIM | 2.1 | 0.1–25.9 | 0.0 | 0.9 | NA | |
blaNDM | 15.1 | 3.7–45.6 | 86.1 | 0.01 | 0.8 | |
blaOXA−48 | 4.9 | 1.4–15.7 | 0.0 | 0.6 | 0.5 | |
blaKPC | 58.8 | 25.3–85.8 | 90.6 | 0.01 | 0.6 | |
Eastern Mediterranean region | Carbapenem | 36.4 | 18.7–58.8 | 75.19 | 0.01 | 0.1 |
blaVIM | 44.4 | 0.5–99.3 | 84.2 | 0.01 | NA | |
blaNDM | 31.9 | 23.8–41.1 | 0.0 | 0.6 | NA | |
blaOXA−48 | 27.1 | 2.1–86.5 | 75.8 | 0.01 | NA | |
blaKPC | NA | NA | NA | NA | NA | |
South-East Asian Region | Carbapenem | 56.4 | 23.6–84.4 | 76.9 | 0.01 | 0.1 |
blaVIM | NA | NA | NA | NA | NA | |
blaNDM | 26.8 | 17.9–38.1 | 0.0 | 0.4 | 0.6 | |
blaOXA−48 | 66.9 | 41.2–85.4 | 71.8 | 0.01 | 0.6 | |
blaKPC | NA | NA | NA | NA | NA | |
European Region | Carbapenem | 50.0 | 22.5–77.5 | 0.0 | 0.9 | NA |
blaVIM | NA | NA | NA | NA | NA | |
blaNDM | NA | NA | NA | NA | NA | |
blaOXA−48 | NA | NA | NA | NA | NA | |
blaKPC | NA | NA | NA | NA | NA | |
African Region | Carbapenem | 95.5 | 55.2–99.7 | 0.0 | 0.9 | NA |
blaVIM | NA | NA | NA | NA | NA | |
blaNDM | 20.0 | 5.0-54.1 | 0.0 | 0.9 | NA | |
blaOXA−48 | 80.0 | 45.9–95.0 | 0.0 | 0.9 | NA | |
blaKPC | NA | NA | NA | NA | NA | |